ARTV - Artiva Biotherapeutics, Inc.

Insider activity in ARTV over the last quarter tilts toward selling: insiders offloaded a net 300,943 shares worth roughly $2.3M. In the past 30 days, 0 insiders bought and 4 sold.

All 4 insiders who sold still hold shares after their sales.

Compare Health Care sector insider flows →

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Ra Capital Management, L.P.	17.33M	$72.78M	-
10%	Gc Corp.	6.00M	$25.20M	-
CEO	Fred Aslan	1.46M	$6.12M	-85,641
COO	Jennifer Bush	357.7K	$1.50M	-8,439
Other	Christopher Horan	302.3K	$1.27M	-10,423

Activity

Buys and sells only

Transactions

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Sep 3, 2026	Christopher Horan	Chief Tech Operations Officer	Sell	10,366	$11.16	$115,637.91	-3.5%	-	-
Sep 3, 2026	Jennifer Bush	COO, CLO, Compliance Officer	Sell	8,391	$11.16	$93,605.80	-2.5%	-	-
Sep 3, 2026	Fred Aslan	Chief Executive Officer	Sell	61,888	$11.16	$690,391.58	-4.0%	-	-
Sep 3, 2026	Subhashis Banerjee	Chief Medical Officer	Sell	1,100	$11.16	$12,271.16	-0.8%	-	-
Aug 27, 2026	Subhashis Banerjee	Chief Medical Officer	Sale+OE10b5-1	8,222	$12.01	$98,735.53	-5.5%	-	-
Aug 18, 2026	Subhashis Banerjee	Chief Medical Officer	Sale+OE10b5-1	429	$12.00	$5,148.00	-0.3%	-	-
Jul 31, 2026	Ra Capital Management, L.P.54	Director, 10% Owner	Buy	45,768	$9.96	$455,725.68	+0.3%	-58.1%	-
Jul 24, 2026	Ra Capital Management, L.P.54	Director, 10% Owner	Buy	41,319	$9.99	$412,776.81	+0.2%	-38.2%	-
Jul 23, 2026	Ra Capital Management, L.P.54	Director, 10% Owner	Buy	264,586	$9.76	$2,583,314.22	+1.6%	-35.9%	-
Jul 17, 2026	Ra Capital Management, L.P.54	Director, 10% Owner	Buy	160,354	$8.93	$1,432,118.86	+1.0%	-37.9%	-

Understand these filings

How to Read SEC Form 4 Filings →Understanding Insider Buying Signals →What is Insider Trading? A Complete Guide →Cluster Buying: When Multiple Insiders Buy Together →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC